Allergy and Infectious Diseases Research federal funding in FY2025

How CFDA 93.855 meets FY2025 in the award file

This page is a join: Allergy And Infectious Diseases Research and fiscal year 2025. $4,539,937,172.09 is the USAspending.gov obligation sum on the yearlyTrend row that carries both tags. It is not every federal dollar in FY2025, not an outlay register, and not a case-count, a vaccine-dose inventory, or an outbreak-week table. The FY cell is 12.5% of the program-wide $36,365,364,946.68 book in this extract. A different fiscal year for CFDA 93.855 is a separate overlay. Campaign-finance tables are a different dataset; FEC donations do not fund these USAspending obligations.

CFDA 93.855 is the listing without the year filter. FY2025 federal spending is the year without this CFDA filter. All programs lists other catalog hubs. All spending ties indexes other pairs. Only this tie applies both filters. 3,261 is the year-cell award-record count; the program parent lists 13,068 awards across the extract. Those counts are different tables.

Allergy and Infectious Diseases Research as the program side of the FY2025 join

The official title is ALLERGY AND INFECTIOUS DISEASES RESEARCH. SpendingVault does not grade Allergy and Infectious Diseases Research. $4,539,937,172.09 is an obligation sum, not a verdict. Confusing this join with other biomedical-research catalog lines that are not CFDA 93.855 would be a different table. Packet facts on the program side are the name Allergy And Infectious Diseases Research, number 93.855, program-wide obligations $36,365,364,946.68, and 13,068 awards on the parent. This packet lists no award recipients and no contractor names.

Allergy And Infectious Diseases Research is CFDA 93.855. FY2025 is a modest slice of a large program parent in this extract; remaining dollars sit on other fiscal years for the same listing. Pathogen-by-pathogen splits are unpublished. Do not treat the year cell as doses shipped or cases averted. Investigator names are unpublished.

What fiscal year 2025 contributes on CFDA 93.855

FY2025 is a USAspending yearlyTrend bucket, not a calendar-year close and not a claim that every obligated dollar was delivered inside calendar 2025. Awards can list FY2025 while performance stretches across adjacent years. FY figures can be incomplete for a current year; this snapshot reports $4,539,937,172.09 as given. Other fiscal years for CFDA 93.855 belong on those ties. Do not treat $36,365,364,946.68 as if it were the FY2025 headline.

3,261 awards on the FY2025 cell, not a unit census

The extract lists 3,261 awards on Allergy and Infectious Diseases Research in FY2025. That is an award-record count, not 3,261 unique laboratories, pathogens, or investigators. Dividing $4,539,937,172.09 by 3,261 yields about $1,392,191.71 as a quotient of two packet facts, not a typical invoice and not a median. Unique recipients are unpublished. Modifications can add rows without naming a new organization. Do not mix $4,539,937,172.09 with the parent’s 13,068 awards.

Obligations on Allergy and Infectious Diseases Research are not cash already cleared in FY2025

An obligation is a legal commitment. An outlay is a payment. $4,539,937,172.09 is the former. Citing it as cash already cleared in FY2025 over-reads the field. The join cannot say that fiscal year 2025 specialized in Allergy and Infectious Diseases Research because of federal demand. Keep $4,539,937,172.09 labeled as Allergy And Infectious Diseases Research obligations in FY2025. It is not a named-lab roster, a pathogen split this packet omits, or a trial-enrollment file.

Open /programs/93.855/ for the program rollup, /fiscal-years/2025/ for the fiscal-year rollup, /programs/ for other CFDA hubs, and /ties/ for other pairs. None of those links convert this cell into a case-count, a vaccine-dose inventory, or an outbreak-week table, into outlays this packet omits, or into a contractor list. Cite both sides: Allergy And Infectious Diseases Research and FY2025, CFDA 93.855, $4,539,937,172.09, 3,261 awards, USAspending.gov, obligations only. Keep Allergy And Infectious Diseases Research and FY2025 on the same line as $4,539,937,172.09.

Questions

How much Allergy and Infectious Diseases Research spending is in FY2025?

USAspending.gov records $4,539,937,172.09 in Allergy And Infectious Diseases Research obligations for FY2025 (CFDA 93.855). That is a program × year join, not an outlay and not the government-wide FY2025 total. Original filings remain on USAspending.gov.

Do 3,261 awards mean 3,261 infectious-disease studies in FY2025?

No. 3,261 is the year-cell award-record count, not 3,261 unique laboratories, pathogens, or investigators. A mean of about $1,392,191.71 is arithmetic on packet facts, not a typical payment. Unique recipients are unpublished. Original filings remain on USAspending.gov.

Is $4,539,937,172.09 cash already paid for Allergy and Infectious Diseases Research in FY2025?

No. $4,539,937,172.09 is an obligation aggregate for Allergy And Infectious Diseases Research in FY2025. Outlays, remaining balances, and cash already paid are unpublished on this packet. Keep the obligation label. USAspending.gov remains the source. Keep Allergy And Infectious Diseases Research and FY2025 together when citing $4,539,937,172.09.

Which pages parent Allergy and Infectious Diseases Research FY2025?

CFDA 93.855 is the program parent. FY2025 federal spending is the year parent. All programs lists other CFDA hubs. All spending ties lists other pairs. Prefer those tables after later ingests; this page quotes Allergy And Infectious Diseases Research × FY2025 at $4,539,937,172.09.